Shockwaves Therapy and Botulinum Toxin for the Treatment of Spasticity in Patients With Cerebral Palsy. A Cross Over RCT

• Status: Completed
• Trial end date: 2016-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Spasticity is a motor disorder that can affect the lower limbs in up to 75% patients with cerebral palsy, having a significantly effect on their mobility and quality of life. There is much controversy about what is the most appropriate treatment of spasticity The objective of the present study is to evaluate the effects of radial extracorporeal shock wave therapy (rESWT) compared to treatment with botulinum toxin to improve spasticity in patients with cerebral palsy

The number needed of patients is 70 (35 per group). Leaving a period of washout between one therapy and the other

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Xavi Vidal Novellas
• Collaborator: Cerebral Palsy Association
• Treatments: abobotulinumtoxinA; Botulinum Toxins; Botulinum Toxins, Type A; incobotulinumtoxinA; onabotulinumtoxinA

Criteria

Inclusion Criteria:

• Age between 5 and 55 years

• Any level of GMFCS (Gross Motor Function Classification System)

• The patient consent to participate in the study

• Diagnosis of spastic cerebral palsy

• Triceps Surae spasticity in them.

• The dynamic foot deformity.

• Extensibility between 0 ° and 20 ° in dorsal flexion passive way.

• Do not be diagnosed important cutaneous alterations.

Exclusion Criteria:

• Associate neuromuscular disease.

• Surgical Intervention to augment the balance articulate and / or reduce the spasticity in the last six months.

• Fixed foot deformity.

• Etiology of factors:

or genetic bone disorders / disturbances soft parts. Position with anomalies or alterations in soft parts or bone alterations (mechanical).

• Unable to follow the treatment.

• Allergy to botulinum toxin.